oxazolidin-2-one has been researched along with Communicable Diseases, Emerging in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Beekmann, SE; Gilbert, DN; Polgreen, PM | 1 |
Broyles, J; Chow, S; Craig, AS; Devasia, RA; Jones, TF; Kainer, MA; Melton, K; Moore, KL; Schaffner, W; Simmons, BP | 1 |
2 other study(ies) available for oxazolidin-2-one and Communicable Diseases, Emerging
Article | Year |
---|---|
Toxicity of extended courses of linezolid: results of an Infectious Diseases Society of America Emerging Infections Network survey.
Topics: Acetamides; Anti-Bacterial Agents; Bacterial Infections; Communicable Diseases, Emerging; Data Collection; Drug Administration Schedule; Humans; Linezolid; Oxazolidinones; Practice Patterns, Physicians'; Societies, Medical; United States | 2008 |
Response to emerging infection leading to outbreak of linezolid-resistant enterococci.
Topics: Acetamides; Anti-Infective Agents; Case-Control Studies; Colony Count, Microbial; Communicable Diseases, Emerging; Cross Infection; Disease Outbreaks; Drug Resistance, Bacterial; Enterococcus faecalis; Enterococcus faecium; Gram-Positive Bacterial Infections; Hospital Mortality; Humans; Length of Stay; Linezolid; Microbial Sensitivity Tests; Multivariate Analysis; Oxazolidinones; Vancomycin Resistance | 2007 |